Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01625650 · ClinicalTrials.gov registry record
Effectiveness Registry to Study Therapies for Arthritis and Inflammatory Conditions: The Corrona CERTAIN Sub-study
A clinical trial of Rheumatoid Arthritis, sponsored by CorEvitas.
- Completed
- Registry status
- 2,795
- Enrollment target
- 1
- Study location
NCT01625650: Completed study of Rheumatoid Arthritis, sponsored by CorEvitas.
NCT01625650 is a study of Rheumatoid Arthritis that has completed, run by CorEvitas. The registered enrollment target is 2,795 participants, below the 4,676-participant average among 197 other Rheumatoid Arthritis trials with a reported enrollment target (40% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01625650, a study of Rheumatoid Arthritis, has completed, sponsored by CorEvitas.
- COMPLETED
- Registry status
- 2,795 participants
- Enrollment target
- 1
- Study location
Study Summary
The CORRONA CERTAIN Sub-study of the Consortium of Rheumatology Researchers of North America, Inc. is a Sub-study of the CORRONA Data Collection Program. The CERTAIN Sub-study is designed to systematically collect and document use patterns, effectiveness, comparative effectiveness and safety of biologic agents used in the management of Rheumatoid Arthritis (RA).
Conditions Studied
Study Locations (1)
New York
- The Center For Rheumatoligy - Albany
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,795 participants |
| Start Date | 2010-10 |
| Est. Completion | 2015-05 |
What the finished NCT01625650 record still lists
NCT01625650 is an observational study that tracks outcomes without assigning an intervention. Its 2,795 participants enrollment target places it among the larger protocols in the corpus, below the 4,676-participant average among 197 other Rheumatoid Arthritis trials with a reported enrollment target (40% lower).
The record links to 1 condition, with Rheumatoid Arthritis appearing as the primary indexed condition, and to 0 interventions.
NCT01625650 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT01625650 about?
NCT01625650 is a clinical study titled "Effectiveness Registry to Study Therapies for Arthritis and Inflammatory Conditions: The Corrona CERTAIN Sub-study". The CORRONA CERTAIN Sub-study of the Consortium of Rheumatology Researchers of North America, Inc. is a Sub-study of the CORRONA Data Collection Program. The CERTAIN Sub-study is designed to systematically collect and document use patterns, effectiveness, comparative effectiveness and safety of bio...
What is the current status of trial NCT01625650?
This trial is currently completed. The enrollment target is 2,795 participants. The study started on 2010-10. Estimated completion is 2015-05.
What conditions does trial NCT01625650 study?
This clinical trial studies the following conditions: Rheumatoid Arthritis.
Who is sponsoring clinical trial NCT01625650?
This trial is sponsored by CorEvitas, which has 13 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01625650 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Rheumatoid Arthritis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01625650's enrollment target sits among peer trials
2,795 10th of 197 higher than 188 of 197 other Rheumatoid Arthritis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Rheumatoid Arthritis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Rheumatology Diet Study
RECRUITING
-
Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable Cancer
RECRUITING · Phase 1
-
EMPHASYS Cup Positioning in THA With Non-Invasive Navigation (Velys Hip Navigation (VHN))
RECRUITING · NA
-
Creating Health Course Study for People With Rheumatological Conditions
RECRUITING · NA
-
Physica System Total Knee Replacement Registry Study
RECRUITING · NA
-
Study of GS-0151 in Participants With Rheumatoid Arthritis
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05443737 · 2,800 participants · Phase 3
Evaluation of a Telehealth Oncofertility Care Intervention in Adolescent and Young Adult Cancer Patients
- NCT05899439 · 2,800 participants
Immune Function and the Progression to T1D
- NCT06089109 · 2,800 participants · NA
Creating VIP Corps to Reduce Maternal Deaths
- NCT06345339 · 2,800 participants · Phase 2
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia